Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study Evaluating the Mass Balance of Micro-dose [14C]HSK3486 Emulsion Injection in Healthy Chinese Male Adults

Trial Profile

A Study Evaluating the Mass Balance of Micro-dose [14C]HSK3486 Emulsion Injection in Healthy Chinese Male Adults

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2019

At a glance

  • Drugs HSK 3486 (Primary)
  • Indications Anaesthesia; Sedation
  • Focus Pharmacokinetics
  • Sponsors Sichuan Haisco Pharmaceutical
  • Most Recent Events

    • 14 Jan 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Apr 2019.
    • 14 Jan 2019 Planned initiation date changed from 30 Dec 2018 to 30 Jan 2019.
    • 27 Dec 2018 Planned initiation date changed from 30 Nov 2018 to 30 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top